Results 281 to 290 of about 419,120 (338)

Reading hominin life history in fossil bones and teeth: methods to test hypotheses regarding its evolution

Biological Reviews, EarlyView.
ABSTRACT Human life history is derived compared to that of our closest living relatives, the great apes. It has been suggested that these derived traits are causally related to aspects of our ecology, social behaviour and cognitive abilities. However, resolving this requires that we know the evolutionary trajectory of our distinctive pattern of growth,
Paola Cerrito, Judith M. Burkart, Carel van Schaik   +2 more
wiley   +1 more source

Evolutionary history, longevity and terrestriality predict <i>Toxoplasma gondii</i> seroprevalence in free-ranging non-human primates. [PDF]

Int J Parasitol Parasites Wildl
Rasambainarivo F, Hinson B, Rasolofoniaina O, Chelaghma S, Junge RE, Metcalf CJE, Williams CV, Rice B.   +7 more
europepmc   +1 more source

Infection Risk From Humans and Animals in the Anatomy Laboratory: A Scoping Review

Clinical Anatomy, EarlyView.
ABSTRACT Whole‐body dissection is a cornerstone of anatomy education. During and following the COVID‐19 pandemic, exposure to infectious agents and other risks of dissection were highlighted. To identify potential risks, one must have the data outlining these risks in specific situations.
Margaret A. McNulty, Elizabeth R. Agosto
wiley   +1 more source

Behind the Trend: An Examination of Primate Content on TikTok. [PDF]

Am J Primatol
Strong KK, Frakes LA, Mayhew JA, Thompson CJ, Ratliff CP.   +4 more
europepmc   +1 more source

Effects of Primate-Specific Long Non-Coding RNAs on Osteoclast Differentiation and Function

Yuki Namba, Takashi Izawa, Gohji Kozaki, Yusaku Hamada, Takanori Ishikawa, Takaaki Tsunematsu, Satoshi Kubota, Hiroshi Kamioka   +7 more
openalex   +1 more source

Biomarkers of Drug‐Induced Kidney Injury: Use in Clinical Trials and Recent Examples of Impact on Drug Development

Clinical Pharmacology &Therapeutics, EarlyView.
This manuscript describes the scope of implementation and impact of a regulatory agency‐qualified panel of six urine biomarkers on drug development, the process for which was conducted and funded by the Critical Path Institute, the Foundation for the National Institutes of Health, and the United States Food and Drug Administration.
Tanja S. Zabka, Michael Lawton, Tom Chu, Gary S. Friedman, Katrina Peron, Stefan R. Sultana, Warren E. Glaab, Nicholas M. P. King   +7 more
wiley   +1 more source

Holotype genome of the lesula provides insights into demography and evolution of a threatened primate lineage. [PDF]

Genome Biol
Jensen A, Horton ER, Koko MB, Detwiler KM, Guschanski K.   +4 more
europepmc   +1 more source

Pediatric Developmental Safety Assessment: Are We Ready for the Next Thalidomide?

Clinical Pharmacology &Therapeutics, EarlyView.
Pediatric drug development has achieved remarkable success in the last 20 years with over 1,000 products studied in pediatric patients. This success has been driven in part by an increased understanding of pediatric disease processes. The aspect that has been largely overlooked is the potential adverse effect of new drugs on pediatric developmental ...
Gilbert J. Burckart, Susan M. Abdel‐Rahman, Gelareh Abulwerdi, Sherbet Samuels, Rebecca Racz, Mohamed A. Mohamoud, Nicholas P. Tatonetti   +6 more
wiley   +1 more source